#ChangetheBeat

Together, we can #ChangetheBeat

Undescribed image
Undescribed image
Undescribed image
Undescribed image
Undescribed image

The MedTech Europe cardiovascular sector group calls for policymakers to deliver on a European Union Policy Plan for cardiovascular health – the most efficient and sustainable way to improve cardiovascular health on a European Union level. Scroll down to discover more of MedTech Europe's work on this topic.

Every beat counts – together, we can drive change.

Since May 2023, the MedTech Europe cardiovascular sector group has been rolling out a social campaign to raise awareness about the need to prioritise cardiovascular health on a European Union level. The campaign has been based on the research and policy recommendations from the publication An EU Action Plan for Better Cardiovascular Health drafted by the Cardiovascular Sector group made of experts from companies that bring solutions to patients’ doorsteps.

Cardiovascular diseases have been widely present among European patients and have affected numerous individuals, healthcare professionals and communities. Today, the medical technology industry provides a wide span of tools and solutions to prevent, diagnose and manage cardiovascular diseases. These include blood tests that identify patients with high cholesterol, high risk of heart attack and heart failure, modern imaging devices that detect narrowing of the arteries and many more. These tools help cardiovascular patients have longer and better lives. However, without a right policy infrastructure to replace the current fragmented policy landscape, change at scale will not be possible.

The time to act is now

A holistic, well-rounded European cardiovascular health plan must prioritise prevention, early detection, diagnostics, and management of cardiovascular diseases. This approach will help pave the way towards positive change for individual patients, communities, and Europe. MedTech Europe’s Cardiovascular Sector group has outlined the A to Z of how a cardiovascular health plan could look like – go here to see how we can get to the heart of cardiovascular diseases.

A financial burden

But there’s more – did you know that the lack of a coherent plan for cardiovascular health causes financial burden? Around €210 billion is spent by European patients every year on cardiovascular diseases – but around €54 billion is spent to loss of productivity. A clearly defined policy framework would enable these resources to be reallocated to research, prevention, and patients in need.

Inequalities in diagnostics and treatment

MedTech Europe’s research showed that there are inequalities in relevant diagnostics and management of cardiovascular diseases across the European Union. For example, access to diagnostics and knowledge on prevention is lower in smaller member states and those with less financial power. Moreover, certain social groups are more exposed and vulnerable to cardiovascular diseases. A coherent policy infrastructure could bring about change to patients across borders, equally. Therefore, a clear European plan for cardiovascular should integrate elements of social equality and inclusivity with the aim of leaving no patient behind.

Let’s get to the heart of cardiovascular diseases

The year 2023 is all about advancing cardiovascular health.​ Setting up a regulatory infrastructure would have multiple benefits, of which the greatest are for both European patients and citizens. Help us put cardiovascular health high on the policymaking agenda – let’s change the beat.

Interested in receiving regular updates & taking part in the campaign? Follow on LinkedIn and Twitter and help us change the beat. #ChangetheBeat

Related content

Join us in promoting the value of medical technologies - download and share the materials below:

Undescribed image

Time to act to change the beat: achieving cardiovascular health for all – Manifesto

Document paper - 29.09.2023

Undescribed image

MedTech Europe Cardiovascular Sector Group’s Response to the European Commission’s Targeted Consultation on EU4Health 2024 Work Programme

Document paper - 10.05.2023

Undescribed image

Early diagnosis can make all the difference to the lives of people with heart failure and other forms of cardiovascular disease

Blog - 12.10.2022

Undescribed image

MedTech Europe’s Diabetes Group contribution to the ‘Healthier Together – EU Non-Communicable Diseases Initiative’

Document paper - 29.04.2022

Undescribed image

An EU Action Plan for Better Cardiovascular Health

Document paper - 25.05.2021

Undescribed image

Your heart has never been more important

Blog - 11.05.2021

Undescribed image

Two heart surgeries and unstoppable

Blog - 12.10.2022

Undescribed image

Achieving Cardiovascular health for All: A new vision for Europe

Blog - 12.10.2022

Undescribed image

Listening to patients drives innovation in heart health

Blog - 12.10.2022

Undescribed image

BEAT methodology, how to improve heart failure prevention

Blog - 12.10.2022

Discover more

Cardiovascular Picture

Cardiovascular

Cardiovascular diseases, including heart failure, atrial fibrillation-related stroke, heart valve disease or coronary heart disease, can impact people of all ages and remain the leading cause of death in the European Union.

The medical technology industry provides high-quality solutions to safeguard and promote cardiovascular health and reduce the burden of cardiovascular diseases on individuals, families, and the wider society.

Undescribed image

What is Medical Technology?

Medical technologies are products, services or solutions used to save and improve people’s lives.

Man hiker Wearing Supportive Leg Brace and gainst the cruthes.

Value of Medical Technology

Medical technologies can save lives, improve health and contribute to sustainable healthcare. Through innovative devices and diagnostics, the industry delivers value to patients, healthcare professionals, and healthcare systems and society. Medical technology companies are also drivers of economic growth and job creation across Europe.